Higher risk groups include: People starting GLP-1 medicines for the first time People whose dose is increased too quickly People who eat large, oily, or very sweet meals People with type 2 diabetes using insulin or sulfonylureas People with previous pancreatitis People with gallstones or gallbladder disease People with severe digestive disorders People with gastroparesis People with kidney disease People with dehydration risk People with diabetic retinopathy People with a personal or family history of medullary thyroid carcinoma People with Multiple Endocrine Neoplasia syndrome type 2 People with active mood disorders or suicidal thoughts People planning surgery or procedures under anaesthesia Patients With Diabetes Vs Non-Diabetic Users People with diabetes may use GLP-1 medicines to improve blood sugar control and support weight management

Learn what to watch for By 6 min read Neuroscience What Is Cognitive Dissonance and Why It Shapes Our Choices Cognitive dissonance is the discomfort you feel when your beliefs and behavior pull in opposite directions
Ozempic was originally approved for treating type 2 diabetes and helps lower hemoglobin A1C levels
Many studies have revealed numerous additional functions of glucagon in the brain, liver, heart, and adipose tissue in addition to its well-known function in regulating blood sugar levels [30,31,32]
Peptides are getting a lot of attention right now, and the discussions around them are evolving